Service

In our free service area you will find informative brochures and an overview of frequently asked questions about many liver-related topics. With just a few clicks you can also see the countries where Hepa-Merz® is available. We wish you all the best for your health!

FAQs

Frequently asked questions by patients with liver disease | more

Downloads

Useful downloads for example Package Leaflets or Dosage Leaflets | more

Obligatory texts Hepa-Merz®

EU:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose,

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019

Merz Pharmaceuticals GmbH, 60048 Frankfurt

LATAM:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019

Merz Pharmaceuticals GmbH, 60048 Frankfurt